News
Vinay Prasad, a top regulator at the US Food and Drug Administration, has left the agency after a controversy over his ...
But this time, the unknown is hitting the industry in a different way from when Prasad was tapped to lead CBER less than ...
This week on "The Readout LOUD," STAT's biotech reporters parse what Vinay Prasad's ouster means for biotech and the FDA.
Hosted on MSN22h
WSJ Opinion: A Shakeup at the FDAJournal Editorial Report: Vinay Prasad exits after gene-therapy reversal. Why Britain faces a bigger Trump tariff blow ...
Vinay Prasad’s ouster as the Food and Drug Administration’s top vaccine and gene therapy regulator came after frustration ...
Vinay Prasad had a problem. Several, actually. His staff at the Food and Drug Administration kept leaking to the press. He ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results